Products Markets Manufacturing Services Blog Who We Are Investor Relations English Home » Investor Relations » Share Information » Dividend Policy Dividend Policy Your trusted and focused solution partner since 1923 Share Ticker Elos Medtech B (ELOS B) Latest +/- % Ask Bid 304 -16 -5.00 304 301 Last update: 4 December 2021, 9:22 This post is also available in: Svenska Elos Medtech’s dividend policy stipulates that the dividend is to be based on the Group’s earnings performance, while taking into account its future development potential and financial position. The long-term goal is for the dividend to increase at a constant rate and to be equivalent to 30-50 per cent of the profit after tax. CALENDAR Feb 24, 2022 Year-end Report 2021 April, 2022 Annual Report 2021 April 26, 2022 Interim Report Q1, 2022 May 3, 2022 Annual General Meeting 2022 Aug 18, 2022 Interim Report Q2, 2022 Oct 21, 2022 Interim Report Q3, 2022 Feb 23, 2023 Year-end Report 2022 PRESS RELEASES & REGULATORY INFORMATION Notice to attend the Extraordinary General Meeting of Elos Medtech AB (publ) 29 Nov 2021, 16:30 Elos Medtech Interim Report January 1 - September 30, 2021 20 Oct 2021, 08:00 Elos Medtech Nomination Committee appointed for the 2022 Annual General Meeting 27 Sep 2021, 11:30 PRESS RELEASES & REGULATORY INFORMATION Notice to attend the Extraordinary General Meeting of Elos Medtech AB (publ) 29 Nov 2021, 16:30 Financial / IR information STAY UPDATED! Subscribe to our newsletter SUBSCRIBE Copyright © 2021 by Elos Medtech AB. All rights reserved. Cookies & Privacy Policy Follow us: This website uses cookies to provide you with the best browsing experience. Find out more or adjust your settings. Accept